Clinical Trial Update: A Comparative Bioavailability Study of Lomitapide 20 mg Intact vs Sprinkled [Phase 1]

View source ↗

Summary

Phase 1 comparative bioavailability study of lomitapide 20 mg intact vs sprinkled in healthy subjects completed; results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Healthy

Drugs mentioned

• Lomitapide (lomitapide)

Snippet

Sponsor: Aegerion Pharmaceuticals, Inc. | Conditions: Healthy | Phase 1 | Status: COMPLETED | Results posted: 2018-02-13